Related Experiment Video
Updated: May 16, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Glucose concentration in seromas after plastic surgery: a pilot study.
Emma Hansson1, Johan Malm, Carolin Freccero
1Department of Clinical Sciences, Malmö, Lund University, Plastic and Reconstructive Surgery, Skåne University Hospital , Malmö , Sweden. emma.hansson@med.lu.se
Journal of Plastic Surgery and Hand Surgery
|November 20, 2012
Summary
This pilot study found that seroma glucose concentration differs from plasma glucose levels. Further research is needed to understand normal seroma glucose ranges and influencing factors.
Area of Science:
- Biochemistry
- Surgical Research
- Medical Diagnostics
Background:
- Glucose concentration is typically assumed to be uniform across seroma, lymph, and plasma.
- Limited empirical data exists on actual glucose levels within seroma fluid.
Purpose of the Study:
- To investigate whether glucose concentration in seroma fluid is comparable to that in plasma.
- To challenge the long-held assumption of similar glucose levels in these bodily fluids.
Main Methods:
- Biochemical analysis of seroma fluid collected from surgical drains.
- Sample collection occurred between postoperative days 3 and 6 from 11 plastic surgery patients.
Main Results:
- The median glucose concentration in seroma was found to be 3.09 millimolar (mM), with a range of 2.25-3.89 mM.
- Seroma glucose levels did not appear to align with previously presumed concentrations in plasma and lymph.
Conclusions:
- The findings suggest a discrepancy between seroma glucose concentration and that of plasma and lymph.
- Further investigation is warranted to establish normal seroma glucose ranges, temporal changes, and correlations with plasma glucose and infection.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...